News Jan 29, 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News Nov 06, 2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News Apr 30, 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News Jul 13, 2022 AstraZeneca and docdok.health improving asthma control AstraZeneca and the Basel-based start-up docdok.health are jointly developing a new digital solution to treat chronic respiratory diseases. Studi...
News Nov 01, 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...
News Oct 25, 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
Aktuell Jul 13, 2022 AstraZeneca und docdok.health verbessern Asthmakontrolle AstraZeneca und das Basler Start-up docdok.health entwickeln gemeinsam eine neue digitale Lösung für die Behandlung von chronischen Erkrankungen ...
News Oct 18, 2022 KetoSwiss secures capital increase of 4 million dollars KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based start-up develops products to alleviate neurological disease...
Actualités Nov 06, 2023 Abionic et Lascco s’associent à Fapon pour le diagnostic du sepsis en Chine Les sociétés du Biopôle, Abionic et Lascco, s’associent à Fapon pour exploiter un biomarqueur révolutionnaire pour la détection de la septicémie,...
Aktuell Oct 18, 2022 KetoSwiss erhöht Kapital um 4 Millionen Dollar KetoSwiss hat von Investoren 4 Millionen Dollar erhalten. Das Basler Start-up entwickelt Produkte zur Linderung neurologischer Erkankungen wie Mi...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News Aug 14, 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
Actualités Oct 26, 2022 Cordis va acquérir la medtech vaudoise MedAlliance pour USD 1,1 milliard Dans le cadre d’une transaction totale pouvant atteindre USD 1,135 milliard, MedAlliance a signé un accord de sortie avec Cordis, un leader mondi...
Actualités Sep 29, 2023 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
Actualités May 11, 2021 Le spécialiste vaudois des traitements ophtalmiques Oculis lève $ 57 millions Oculis, société biopharmaceutique spécialisée dans le développement de traitements ophtalmiques innovants, a annoncé la clôture d’un tour de fina...
Actualités Oct 06, 2020 SOPHiA GENETICS lève 110 millions de dollars Leader mondial de la médecine basée sur les données, SOPHiA GENETICS a conclu un tour de financement de 110 millions de dollars pour entrer dans ...